8-K - Kairos Pharma, LTD. (0001962011) (Filer)
Published . Updated .
Filed: 2026-10-06 AccNo: 0001493152-26-045844 Size: 220 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Directly affected
- KAPA Kairos Pharma
Named in this report.
Indirectly affected
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DVA DaVita HealthCare Partners, Inc.
GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BBIO BRIDGEBIO PHARMA INC
GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- GEHC GE HEALTHCARE TECHNOLOGIES I
GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Filed: 2026-10-06 AccNo: 0001493152-26-045844 Size: 220 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 6 Oct 2026: Kairos Pharma (KAPA) versus the S&P 500
Since the first closing price after “8-K - Kairos Pharma, LTD. (0001962011) (Filer),” Kairos Pharma (KAPA) is -36.94%. The S&P 500 fund (SPY) is -1.36% over the same days, a -35.59% difference versus the market.
Who reported a Kairos Pharma (KAPA) trade near this story
- Gilbert Cisneros sell BridgeBio Pharma (BBIO) ($1,001 - $15,000). That is 7 days before publication, inside 30 days. The filing is listed beside the story “8-K - Kairos Pharma, LTD. (0001962011) (Filer).”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 25 days before publication, inside 30 days. The filing is listed beside the story “8-K - Kairos Pharma, LTD. (0001962011) (Filer).”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Kairos Pharma, LTD. (0001962011) (Filer)”
Companies tied to this story
- KAPA Kairos Pharma
In “8-K - Kairos Pharma, LTD. (0001962011) (Filer),” Kairos Pharma (KAPA) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> KAPA
- ACHC Acadia Healthcare
Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence in the 6 Oct 2026 story “8-K - Kairos Pharma, LTD. (0001962011) (Filer).” Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DVA Davita
Davita (DVA) is linked, with no stored direction, medium confidence in the 6 Oct 2026 story “8-K - Kairos Pharma, LTD. (0001962011) (Filer).” Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
In “8-K - Kairos Pharma, LTD. (0001962011) (Filer),” Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence. Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence in the 6 Oct 2026 story “8-K - Kairos Pharma, LTD. (0001962011) (Filer).” Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
For “8-K - Kairos Pharma, LTD. (0001962011) (Filer),” BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence. Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- GEHC GE HealthCare Technologies
For “8-K - Kairos Pharma, LTD. (0001962011) (Filer),” GE HealthCare Technologies (GEHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “8-K - Kairos Pharma, LTD. (0001962011) (Filer)” reaches Kairos Pharma (KAPA)
The 6 Oct 2026 story “8-K - Kairos Pharma, LTD. (0001962011) (Filer)” names Kairos Pharma (KAPA) because of this story.
The link for Kairos Pharma (KAPA) is this: SEC 8-K filing -> direct issuer disclosure -> KAPA
A second company, Acadia Healthcare (ACHC), is listed for a different reason: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Price levels for Kairos Pharma (KAPA)
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. DVA traded between 174.10 and 189.79 across 20 sessions. The latest close on file is 187.06. KAPA traded between 0.56 and 2.15 across 10 sessions. The latest close on file is 0.58.
How strong the case is around Kairos Pharma (KAPA)
46 out of 100
“8-K - Kairos Pharma, LTD. (0001962011) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.